Scientists at Sechenov University have developed an innovative Nette-MG needle for safe access to the abdominal cavity before laparoscopic surgeries. This new tool is planned for implementation into practice after the completion of clinical trials and registration as a medical device, which is expected in 2025.
The main advantage of the Nette-MG needle compared to the traditional Veress needle is the improved accuracy in determining the moment of penetration into the abdominal cavity. The Veress needle can make it difficult for the surgeon to accurately determine this moment due to the lack of clear indicators. In case of doubt, doctors resort to drop tests or gas insufflation, which can be inconvenient and not always reliable.
The new Nette-MG needle eliminates the need for additional procedures and expensive modifications equipped with sensors. It significantly simplifies the process and reduces the risk of damage to internal organs.
Currently, preclinical studies are being conducted on laboratory animals. After completing all the necessary procedures, including the publication of the experiment results in a scientific journal, the Nette-MG needle will be ready for clinical use.
Read related materials:
In Russia, they learned how to grow cartilage for the knee joint